Analyst Ratings for Neurocrine Bio. (NBIX)
NBIX Rating Summary
NBIX Price Target Summary
- Highest: $204.00 (Citi)
- Lowest: $140.00 (BMO Capital)
- Average: $173.61
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$173.61 (+35.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$173.61 (+35.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
160.00 (N/A) |
128.63 (128.13) |
-0.39% | Details |
| 1/8/2026 | Morgan Stanley » Updated 2/12/2026 |
Jeffrey Hung | Downgrade | Equalweight (Overweight) |
173.00 (175.00) |
137.35 (128.13) |
-6.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
